362 related articles for article (PubMed ID: 11723077)
21. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
Rohlfing CL; Wiedmeyer HM; Little RR; England JD; Tennill A; Goldstein DE
Diabetes Care; 2002 Feb; 25(2):275-8. PubMed ID: 11815495
[TBL] [Abstract][Full Text] [Related]
22. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
23. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
24. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
Inoue K; Matsumoto M; Akimoto K
Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
[TBL] [Abstract][Full Text] [Related]
25. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
26. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
Harris MI;
Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
[TBL] [Abstract][Full Text] [Related]
27. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
28. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
29. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
[TBL] [Abstract][Full Text] [Related]
30. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.
Hadjadj S; Coisne D; Mauco G; Ragot S; Duengler F; Sosner P; Torremocha F; Herpin D; Marechaud R
Diabet Med; 2004 Apr; 21(4):305-10. PubMed ID: 15049930
[TBL] [Abstract][Full Text] [Related]
33. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.
Malone JK; Kerr LF; Campaigne BN; Sachson RA; Holcombe JH;
Clin Ther; 2004 Dec; 26(12):2034-44. PubMed ID: 15823767
[TBL] [Abstract][Full Text] [Related]
34. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
35. The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients.
Dworacka M; Winiarska H
Dis Markers; 2005; 21(3):127-32. PubMed ID: 16276006
[TBL] [Abstract][Full Text] [Related]
36. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
37. Relationship between glycated haemoglobin levels and mean glucose levels over time.
Nathan DM; Turgeon H; Regan S
Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria.
Di Pino A; Scicali R; Calanna S; Urbano F; Mantegna C; Rabuazzo AM; Purrello F; Piro S
Diabetes Care; 2014 May; 37(5):1447-53. PubMed ID: 24574348
[TBL] [Abstract][Full Text] [Related]
39. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.
Kilpatrick ES; Rigby AS; Atkin SL
Clin Chem; 2007 May; 53(5):897-901. PubMed ID: 17384010
[TBL] [Abstract][Full Text] [Related]
40. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).
Monnier L; Lapinski H; Colette C
Diabetes Care; 2003 Mar; 26(3):881-5. PubMed ID: 12610053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
